X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2316) 2316
Publication (297) 297
Book Review (34) 34
Newsletter (31) 31
Book Chapter (13) 13
Conference Proceeding (7) 7
Dissertation (4) 4
Newspaper Article (4) 4
Magazine Article (2) 2
Web Resource (2) 2
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1599) 1599
index medicus (1481) 1481
oseltamivir (1339) 1339
influenza (1234) 1234
influenza, human - drug therapy (848) 848
antiviral agents - pharmacology (784) 784
influenza, human - virology (723) 723
antiviral agents - therapeutic use (712) 712
viruses (677) 677
animals (619) 619
infectious diseases (616) 616
oseltamivir - pharmacology (605) 605
virology (567) 567
drug resistance, viral (535) 535
neuraminidase - antagonists & inhibitors (517) 517
influenza a virus, h1n1 subtype - drug effects (515) 515
female (508) 508
oseltamivir - therapeutic use (478) 478
antiviral agents (475) 475
influenza, human - epidemiology (466) 466
zanamivir (457) 457
male (454) 454
pharmacology & pharmacy (452) 452
resistance (419) 419
pandemics (417) 417
neuraminidase - genetics (414) 414
virus diseases (413) 413
mutation (407) 407
health aspects (381) 381
microbiology (372) 372
adult (369) 369
neuraminidase inhibitors (366) 366
influenza a virus, h1n1 subtype - genetics (363) 363
drug resistance (323) 323
oseltamivir phosphate (309) 309
infection (308) 308
infections (308) 308
influenza viruses (307) 307
research (294) 294
child (289) 289
middle aged (289) 289
analysis (266) 266
neuraminidase (266) 266
adolescent (262) 262
in-vitro (257) 257
influenza, human - prevention & control (257) 257
medicine (248) 248
influenza a virus, h1n1 subtype - isolation & purification (242) 242
drug resistance, viral - genetics (241) 241
drug therapy (239) 239
immunology (235) 235
enzyme inhibitors - pharmacology (226) 226
neuraminidase - metabolism (222) 222
child, preschool (221) 221
mice (218) 218
dogs (215) 215
epidemics (214) 214
viral proteins - genetics (207) 207
aged (206) 206
influenza a virus - drug effects (206) 206
antiviral agents - administration & dosage (204) 204
h1n1 (201) 201
research article (197) 197
avian influenza (194) 194
inhibitors (191) 191
infant (186) 186
surveillance (185) 185
young adult (182) 182
cell line (180) 180
children (180) 180
a virus (179) 179
multidisciplinary sciences (177) 177
influenza a (176) 176
oseltamivir resistance (176) 176
influenza a virus (174) 174
zanamivir - pharmacology (173) 173
susceptibility (171) 171
efficacy (170) 170
exo-a-sialidase (169) 169
treatment outcome (162) 162
public health (161) 161
virus (160) 160
hemagglutinin (158) 158
influenza a virus, h3n2 subtype - drug effects (157) 157
swine influenza (155) 155
transmission (155) 155
united-states (154) 154
prevention (152) 152
a viruses (151) 151
medicine, general & internal (151) 151
mortality (148) 148
antivirals (147) 147
respiratory tract diseases (147) 147
science (145) 145
emergence (143) 143
article (142) 142
antiviral agents - chemistry (141) 141
amantadine (137) 137
safety (136) 136
enzyme inhibitors - therapeutic use (135) 135
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2278) 2278
Russian (24) 24
Japanese (22) 22
French (12) 12
German (11) 11
Chinese (9) 9
Spanish (7) 7
Dutch (6) 6
Korean (5) 5
Swedish (4) 4
Croatian (1) 1
Czech (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 5/2013, Volume 56, Issue 9, pp. 1197 - 1205
Journal Article
Journal Article
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 12/2018, Volume 31, Issue 6, pp. 520 - 526
PURPOSE OF REVIEWNeuraminidase inhibitors (NAIs), including oseltamivir, zanamivir, and peramivir, is the main class of antiviral available for clinical use.... 
INFECTIOUS DISEASES | antiviral resistance | PUBLIC-HEALTH | INTRAVENOUS ZANAMIVIR | SUSCEPTIBILITY | EMERGENCE | A(H7N9) VIRUS | OSELTAMIVIR RESISTANCE | influenza virus | DOUBLE-BLIND | neuraminidase inhibitors | MUTATIONS | PCR | Enzymes | Care and treatment | Enzyme inhibitors | Influenza | Development and progression | Hydrolases | Health aspects
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 03/2013, Volume 207, Issue 5, pp. 709 - 720
Journal Article
Journal Article